Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03120468
EARLY_PHASE1

Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder

Sponsor: Nassima Ait-Daoud Tiouririne

View on ClinicalTrials.gov

Summary

This is a pilot study designed to evaluate the safety, tolerability of Topiramate (TPM) + N-Acetyl Cysteine (NAC) in combination versus Topiramate (TPM) + placebo for the treatment of alcohol use disorder (AUD).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

17

Start Date

2017-05-01

Completion Date

2019-06-30

Last Updated

2026-05-27

Healthy Volunteers

No

Conditions

Interventions

DRUG

Topiramate and N-Acetyl Cysteine

Topiramate up to 200 mg/day and N-Acetyl Cysteine 600 mg twice a day for 12 weeks

DRUG

Topiramate and Placebo

Topiramate up to 200 mg/day and Placebo for 12 weeks

Locations (1)

UVA Center for Leading Edge Addiction Research

Charlottesville, Virginia, United States